SANA Powder

Creatine-Dependent Thermogenesis

SANA is primarily studied for its effects on **creatine-dependent energy expenditure** in adipose tissue. Published research observed increased mitochondrial respiration in fat cells and metabolic changes associated with thermogenesis. In the tested models, these effects also appeared under conditions independent of the classical **UCP1** thermogenic pathway. This makes SANA a useful tool for investigating non-classical heat production, although its complete set of direct molecular targets has not yet been established.

At the cellular level, SANA can be used to investigate how adipocytes regulate **oxygen consumption, mitochondrial respiration, and energy use**. Researchers may combine oxygen-consumption assays with metabolomics, creatine-pathway measurements, and thermogenic gene-expression analysis. Published work also examined its activity under thermoneutral conditions, helping distinguish compound-associated responses from those caused solely by cold exposure. Changes in a single gene or respiration measurement should be interpreted alongside other experimental evidence.

SANA has been investigated in high-fat-diet mouse models to study **body-weight changes and energy balance**. Published experiments reported changes in weight, fat mass, and metabolic measurements, with the parent compound salicylate included as a comparator. Studies using SANA powder should assess food intake, body composition, energy expenditure, and nutrient absorption alongside body weight to clarify the observed effects. Findings in mice cannot be directly translated into claims of weight loss in humans.

SANA is also used to explore the connection between adipose-tissue thermogenesis and **whole-body metabolic regulation**. Preclinical research reported changes in measures related to insulin resistance, glucose tolerance, and liver steatosis. These findings support its use in studies of metabolic interactions among adipose tissue, skeletal muscle, and the liver. The causal relationships among these effects still require further investigation, including tissue-specific and longer-term studies.

Neuroprotection & Neurodegenerative Disease Research

Attenuation of Microglial Activation: Suppresses the hyperactivation of central nervous system microglia induced by lipopolysaccharides (LPS) or amyloid-beta (Aβ) proteins, downregulating the expression of pro-inflammatory cytokines such as TNF-α and IL-1β.

Preservation of Synaptic Plasticity: Protects dopaminergic neurons from neurotoxic damage in Alzheimer's disease (AD) and Parkinson's disease (PD) cell models.

Cardiovascular & Endothelial Protection

Endothelial Barrier Repair: Reduces vascular endothelial cell apoptosis induced by high glucose or oxidized low-density lipoprotein (ox-LDL), promoting eNOS expression and nitric oxide (NO) release to maintain endothelial homeostasis.

Protection Against Myocardial Ischemia/Reperfusion Injury: Maintains mitochondrial membrane potential and inhibits the pathological opening of the mitochondrial permeability transition pore (mPTP) in cardiomyocytes.

Hepatic Metabolism & Anti-Fibrotic Protection

Inhibition of Hepatic Stellate Cell (HSC) Activation: Downregulates the TGF-β1 / Smad signaling pathway to reduce excessive extracellular matrix (ECM) deposition, making it valuable for mechanistic studies on metabolic dysfunction-associated steatohepatitis (MASH/MASLD) and liver fibrosis interception.

Cell Cycle & Apoptosis Regulation

Stress Response Modulation: Modulates the Bcl-2 / Bax expression ratio in tumor microenvironment and cellular stress assays, preventing non-specific apoptosis of healthy tissue cells under chemotherapy or radiation exposure.